Actualités
The GABA excitatory/inhibitory shift in brain maturation and neurological disorders
Ionic currents and the network-driven patterns they generate differ in immature and adult neurons: The developing brain is not a « small adult brain. » One of the most investigated examples is the developmentally regulated shift of actions of the transmitter GABA that inhibit adult neurons but excite immature ones because of an initially higher intracellular chloride concentration [Cl(-)](i), leading to depolarizing and often excitatory actions of GABA instead of hyperpolarizing and inhibitory actions. The levels of [Cl(-)](i) are also highly labile, being readily altered transiently or persistently by enhanced episodes of activity in relation to synaptic plasticity or a variety of pathological conditions, including seizures and brain insults. Among the plethora of channels, transporters, and other devices involved in controlling [Cl(-)](i), two have emerged as playing a particularly important role: the chloride importer NKCC1 and the chloride exporter KCC2. Here, the authors stress the importance of determining how [Cl(-)](i) is dynamically regulated and how this affects brain operation in health and disease. In a clinical perspective, agents that control [Cl(-)](i) and reinstate inhibitory actions of GABA open novel therapeutic perspectives in many neurological disorders, including infantile epilepsies, autism spectrum disorders, and other developmental disorders.
Yehezkel Ben-Ari 1 , Ilgam Khalilov, Kristopher T Kahle, Enrico Cherubini
Articles Scientifiques
- Des volumes cérébraux plus petits après la naissance par césarienne 24 mars 2021
- La séquence de développement du GABA est altérée dans un modèle souris du syndrome de Rett 26 juin 2019
- Aucun signal d’arrêt de croissance autour de la naissance dans un modèle rongeur autiste 24 janvier 2019
- L’activation immunitaire pendant la gestation entraîne des altérations neuronales de l’hippocampe dès la naissance 4 novembre 2018
- Un essai multicentrique prometteur pour atténuer les troubles autistiques 14 mars 2017
- Treating Fragile X syndrome with the diuretic bumetanide: a case report 10 juin 2013
- A randomised controlled trial of bumetanide in the treatment of autism in children 11 décembre 2012
- The GABA excitatory/inhibitory shift in brain maturation and neurological disorders 18 octobre 2012